NOV.DE vs. ASWC.DE
NOV.DE (Novo Nordisk A/S) is a stock, while ASWC.DE (HANetf Future of Defence UCITS ETF Acc EUR) is Aerospace & Defense fund tracking the EQM Future of Defence Index. Over the past year, NOV.DE returned -39.21% vs 16.04% for ASWC.DE. At a 0.24 correlation, their price movements are largely independent.
Performance
NOV.DE vs. ASWC.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NOV.DE achieves a -10.57% return, which is significantly lower than ASWC.DE's 13.04% return.
NOV.DE
- 1D
- 4.26%
- 1M
- -1.56%
- YTD
- -10.57%
- 6M
- -2.27%
- 1Y
- -39.21%
- 3Y*
- -17.58%
- 5Y*
- 5.10%
- 10Y*
- 9.63%
ASWC.DE
- 1D
- -0.80%
- 1M
- 8.64%
- YTD
- 13.04%
- 6M
- 15.13%
- 1Y
- 16.04%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NOV.DE vs. ASWC.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | -10.57% | -45.91% | -9.75% | 30.56% |
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR | 13.04% | 38.30% | 39.36% | 14.35% |
Correlation
The correlation between NOV.DE and ASWC.DE is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2023 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOV.DE vs. ASWC.DE — Risk / Return Rank
NOV.DE
ASWC.DE
NOV.DE vs. ASWC.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NOV.DE | ASWC.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.54 | ||
| Sortino ratioReturn per unit of downside risk | -2.05 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.16 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | 1.36 | -2.04 |
| Martin ratioReturn relative to average drawdown | -1.02 | 3.10 | -4.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NOV.DE | ASWC.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.70 | 0.84 | -1.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 1.91 | -1.41 |
Drawdowns
NOV.DE vs. ASWC.DE - Drawdown Comparison
The maximum NOV.DE drawdown since its inception was -76.64%, which is greater than ASWC.DE's maximum drawdown of -12.58%. Use the drawdown chart below to compare losses from any high point for NOV.DE and ASWC.DE.
Loading charts...
Drawdown Indicators
| NOV.DE | ASWC.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.64% | -12.58% | -64.06% |
Max Drawdown (1Y)Largest decline over 1 year | -54.59% | -12.58% | -42.01% |
Max Drawdown (3Y)Largest decline over 3 years | -76.64% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -76.64% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -76.64% | — | — |
Current DrawdownCurrent decline from peak | -70.56% | -2.83% | -67.73% |
Average DrawdownAverage peak-to-trough decline | -12.76% | -2.47% | -10.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.00% | 5.51% | +31.49% |
Volatility
NOV.DE vs. ASWC.DE - Volatility Comparison
Novo Nordisk A/S (NOV.DE) has a higher volatility of 8.55% compared to HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE) at 5.89%. This indicates that NOV.DE's price experiences larger fluctuations and is considered to be riskier than ASWC.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOV.DE | ASWC.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.55% | 5.89% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 39.45% | 15.89% | +23.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.45% | 20.35% | +33.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.93% | 19.12% | +18.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.39% | 19.12% | +14.27% |
Dividends
NOV.DE vs. ASWC.DE - Dividend Comparison
NOV.DE's dividend yield for the trailing twelve months is around 4.11%, while ASWC.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NOV.DE Novo Nordisk A/S | 4.11% | 3.54% | 1.58% | 1.01% | 1.17% | 1.27% | 1.98% | 2.08% | 27.19% | 2.27% | 3.67% | 1.25% |
Frequently Asked Questions
NOV.DE and ASWC.DE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOV.DE and ASWC.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer